Original Research Article
Year: 2021 | Month: January | Volume: 11 | Issue: 1 | Pages: 54-60
Pre and Post Treatment Comparison between IPL and LipiFlow for Meibomian Gland Dysfunction
Mantu Akon1, Aayushi Gupta1, Priyanjit Kumar Kayal2
1Department of Optometry, CT University, Ludhiana (India)
2Department of Radiology, Calcutta National Medical College, Kolkata (India)
Corresponding Author: Mantu Akon
ABSTRACT
A prospective clinical study was conducted on subjects with meibomian gland dysfunction. All the subjects were first provided with an Ocular Surface Disease Index (OSDI) questionnaire and further evaluation was done on the basis of tests such as TBUT, Schirmer’s Test one (with topical anaesthesia) and LipiView. In consideration of the tests 50 subjects were selected and were divided into two groups in the account of the treatments they were going to receive. 25 subjects were given IPL treatment (Group-1) while the rest 25 were provided with Lipiflow treatment (Group-2). After 1 month of their respective treatments all the 50 subjects were evaluated again on the basis of the tests carried out in the pre evaluation. The post-evaluation after one month of follow-up showed a significant increase in LLT and a significant decrease of meibomian gland dropout in both groups. A notable increase of TBUT was seen in the Group-1 as well as Group-2. Pre and post Schirmer level remain almost unchanged in the subjects of both groups. Both treatments are equally effective in patients in meibomian gland dysfunction. The only difference is that IPL treatment is cost- efficient whereas Lipiflow treatment is time efficient.
Key words: Meibomian Gland Dysfunction; Intense Pulsed Light, Ocular Surface Disease Index.